Mingtiandi’s return to Tokyo on Wednesday brought together 227 senior executives for Japan’s largest real estate investment event of 2025, featuring interviews and insights from le... Read More>>
Asia Pacific real estate investment news and information
With nearly a third of Japan’s population aged at 65 or over, life science and R&D real estate presents a compelling opportunity for property investors seeking to capitalise on rising healthcare demand and increasing pharmaceutical research and development, according to senior executives from Warburg Pincus, Lendlease, and CBRE speaking at Mingtiandi’s 2024 Tokyo Forum. Read the full story>>